News | July 26, 2022
WuXi STA opens a new large scale continuous manufacturing plant
Better serving global partners and advancing healthcare innovation
The company now exceeds the sector benchmark for its overall ESG rating and for all three measures
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Manish led SeQuent since 2014 and played a major role in transforming the company
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
Subscribe To Our Newsletter & Stay Updated
